Antibody based reagents that specifically recognize toxic oligomeric forms of tau
申请人:Oligomerix, Inc.
公开号:US10465001B2
公开(公告)日:2019-11-05
The invention relates to antibodies, antibody fragments and binding agents that specifically recognize oligomeric tau but do not bind to monomelic tau, fibrillar tau or non-disease associated forms of tau.
本发明涉及抗体、抗体片段和结合剂,它们能特异性识别低聚 tau,但不与单体 tau、纤维状 tau 或非疾病相关形式的 tau 结合。